Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1591 AL 1605

Metals and neurodegenerative diseases. A systematic review

Cicero CE, Mostile G, Vasta R, Rapisarda V, Signorelli SS, Ferrante M, Zappia M, Nicoletti A.

Environ Res. 2017 Nov;159:82-94. doi: 10.1016/j.envres.2017.07.048. Epub 2017 Aug 1.

Hypersomnia in Neurodegenerative Diseases

Bhat S, Chokroverty S.

Sleep Med Clin. 2017 Sep;12(3):443-460. doi: 10.1016/j.jsmc.2017.03.017. Epub 2017 Jun 16.

Sex-Specific Gene Expression and Life Span Regulation

Tower J.

Trends Endocrinol Metab. 2017 Oct;28(10):735-747. doi: 10.1016/j.tem.2017.07.002. Epub 2017 Aug 2.

Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease

Surmeier DJ, Halliday GM, Simuni T.

Exp Neurol. 2017 Dec;298(Pt B):202-209. doi: 10.1016/j.expneurol.2017.08.001. Epub 2017 Aug 2.

Evidence for association between hepatitis C virus and Parkinson's disease

Abushouk AI, El-Husseny MWA, Magdy M, Ismail A, Attia A, Ahmed H, Pallanti R, Negida A.

Neurol Sci. 2017 Nov;38(11):1913-1920. doi: 10.1007/s10072-017-3077-4. Epub 2017 Aug 5.

Implications of Circadian Rhythm in Dopamine and Mood Regulation

Kim J, Jang S, Choe HK, Chung S, Son GH, Kim K.

Mol Cells. 2017 Jul 31;40(7):450-456. doi: 10.14348/molcells.2017.0065. Epub 2017 Jul 31.

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Athauda D, Maclagan K, Skene SS, Bajwa-Joseph M, Letchford D, Chowdhury K, Hibbert S, Budnik N, Zampedri L, Dickson J, Li Y, Aviles-Olmos I, Warner TT, Limousin P, Lees AJ, Greig NH, Tebbs S, Foltynie T.

Lancet. 2017 Oct 7;390(10103):1664-1675. doi: 10.1016/S0140-6736(17)31585-4. Epub 2017 Aug 3.

Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review

Campêlo CLDC, Silva RH.

Parkinsons Dis. 2017;2017:4318416. doi: 10.1155/2017/4318416. Epub 2017 Jul 11.

Contribution of language studies to the understanding of cognitive impairment and its progression over time in Parkinson's disease

Auclair-Ouellet N, Lieberman P, Monchi O.

Neurosci Biobehav Rev. 2017 Sep;80:657-672. doi: 10.1016/j.neubiorev.2017.07.014. Epub 2017 Aug 3.

Critical appraisal of clinical trials in multiple system atrophy: Toward better quality

Castro Caldas A, Levin J, Djaldetti R, Rascol O, Wenning G, Ferreira JJ; Movement Disorders Society MSA Study Group.

Mov Disord. 2017 Oct;32(10):1356-1364. doi: 10.1002/mds.27080. Epub 2017 Aug 7.

Cascade stomach associated with delayed-on or no-on phenomenon in a patient with Parkinson's disease

Miyaue N, Tada S, Ando R, Yabe H, Nishikawa N, Nagai M, Nomoto M.

Mov Disord. 2017 Oct;32(10):1492-1493. doi: 10.1002/mds.27109. Epub 2017 Aug 7.

Evolution of Diagnostic Tests for Chronic Wasting Disease, a Naturally Occurring Prion Disease of Cervids

Haley NJ, Richt JA.

Pathogens. 2017 Aug 5;6(3):35. doi: 10.3390/pathogens6030035.

Focusing on heel strike improves toe clearance in people with Parkinson's disease: an observational pilot study

Ginis P, Pirani R, Basaia S, Ferrari A, Chiari L, Heremans E, Canning CG, Nieuwboer A.

Physiotherapy. 2017 Dec;103(4):485-490. doi: 10.1016/j.physio.2017.05.001. Epub 2017 May 22.

Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease

Patel D, Witt SN.

Oxid Med Cell Longev. 2017;2017:4829180. doi: 10.1155/2017/4829180. Epub 2017 Jul 12.

Severe Parkinsonism and Creatine Kinase Increase After Low-Dose Aripiprazole Treatment in a Patient of African Descent

Jørgensen A, Thorleifsson A, Jimenez-Solem E, Werge T, Rasmussen HB.

J Clin Psychopharmacol. 2017 Oct;37(5):630-631. doi: 10.1097/JCP.0000000000000750.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias